Filing Details
- Accession Number:
- 0001209191-18-024125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-05 18:08:59
- Reporting Period:
- 2018-04-03
- Accepted Time:
- 2018-04-05 18:08:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035354 | Eloxx Pharmaceuticals Inc. | ELOX | Services-Commercial Physical & Biological Research (8731) | 841368850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726027 | Gilad Shabtai | C/O Eloxx Pharmaceuticals, Inc. 950 Winter Street, 4Th Floor North Waltham MA 02451 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-03 | 5,700 | $9.41 | 3,274,170 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-04-04 | 2,600 | $9.58 | 3,276,770 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.413, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.69666, inclusive.
Billionaire Hedge Funds
